[ad_1]
Business Wire India
SEASUN BIOMATERIALS (CEO: Park Heekyung), a molecular diagnostic company has made its molecular diagnostic system ‘4S’ (SEASUNBIO SMART SHIELD SYSTEM) available at the Seoul National University (SNU) campus after the launching at Incheon International Airport.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210504005599/en/
SEASUN BIOMATERIALS' 4S system, a one-stop COVID-19 molecular diagnostic system located on the Seoul National University campus. (Photo: Business Wire)
The 4S on-site diagnostic system is a mobile molecular-laboratory equipped with negative pressure rooms and self-powered equipment for molecular diagnostics intended for rapid molecular examination and prevention of infectious diseases such as COVID-19. The entire procedure of COVID-19 diagnostics takes less than 1 hour which consists of filling out a brief questionnaire, sample collection, nucleic acid extraction, molecular detection and sending report results to customers' mobile phones.
Since January 2021, SEASUN BIOMATERIALS’ AQ-TOP Plus has been used for COVID-19 detection in the 'COVID-19 Test Center' established at Incheon International Airport (ICN). The test results are reported within 2 hours at ICN. The passengers and ICN staff are very satisfied with the rapid and accurate procedure of the AQ-TOP Plus.
SEASUN BIOMATERIALS has two (2) diagnostic platforms of COVID-19 diagnostics, U-TOP COVID-19 and AQ-TOP COVID-19 Series. U-TOP COVID-19 Series is intended for the detailed examination which simultaneously discriminates S gene mutations in addition to the parallel examination of four (4) SARS-CoV-2 genes. AQ-TOP COVID-19 Series is intended for a rapid point-of-care test which is optimized for field diagnostics that requires high accuracy within a short testing time.
All COVID-19 related products of SEASUN BIOMATERIALS used in the 4S system have been officially approved by the MFDS, certified ‘Brand K’, CE-IVD marking and authorized under EUA from the US FDA, and have been exported globally since the first wave of the pandemic.
For more information, please visit www.seasunbio.com and https://youtu.be/QP6Tu9vy8Xk.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005599/en/
[ad_2]
Source link
Virter is a dynamic Virtual Reporter specializing in technology, startups, and emerging trends in the digital world. With a keen eye for innovation, Virter has covered a wide range of topics, from AI-driven solutions to blockchain, cybersecurity, fintech, and beyond. Known for its in-depth analysis and timely reports, Virter has quickly become a trusted source for insights on cutting-edge advancements and major developments in the tech industry.
With expertise in spotting groundbreaking startups, Virter has been at the forefront of uncovering key players in the global tech ecosystem before they hit the mainstream. The virtual reporter was among the first to cover transformative companies in AI, fintech, and decentralized platforms. Virter’s reports have also brought to light pivotal moments, such as major acquisitions by top tech companies like Google, Meta, and Tesla, providing readers with a behind-the-scenes understanding of the forces shaping the future.
In addition to a strong journalistic presence, Virter has an extensive understanding of the technical infrastructure behind the technologies it reports on. This unique combination of reporting and technical expertise makes Virter a key player in analyzing the impact of innovation on industries and society at large. Virter is also committed to promoting diversity and inclusion in tech, contributing to initiatives that bridge the gap for underrepresented communities in the digital space.
Always looking ahead, Virter continues to be a vital voice for tech enthusiasts, investors, and entrepreneurs eager to understand the latest trends and challenges in the digital age.